7-amino-2,3-dihydro-1H-inden-4-ol
3 Inquiries
1825352-65-5
99%
Bottle,barrel,cargo,container,etc.
Yes
2026-10-27
Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionKeywords
1825352-65-5
7-amino-2,3-dihydro-1H-inden-4-ol
Quick DetailsProName:7-amino-2,3-dihydro-1H-inden-4-ol
CasNo:1825352-65-5
Appearance:powder, or liquid
Application:Pharmaceuticals, intermediates, APIs, custom synthesis, chemicals
DeliveryTime:5-7 Days
PackAge:Bottle, barrel, cargo, container, etc.
Port:Shanghai
Purity:99
Storage:Stored in room temperature, ventilated place
Transportation:By air, ship, express, etc.
LimitNum:0
Grade:Industrial Grade
SuperiorityBest Seller, High Quality, Competitive Price, Fast Delivery, Quick Response
DetailsLEAPChem supplies high quality Pharmaceuticals, intermediates, APIs, custom synthesis, fine chemicals and other industrial chemicalsECHEMI Editorial ReferenceRisdiplam is an orally bioavailable mRNA splicing modifier used for the treatment of spinal muscular atrophy (SMA). It increases systemic SMN protein concentrations by improving the efficiency of SMN2 gene transcription. This mechanism of action is similar to its predecessor [nusinersen], the biggest difference being their route of administration: nusinersen requires intrathecal administration, as does the one-time gene therapy [onasemnogene abeparvovec], whereas risdiplam offers the ease of oral bioavailability. Risdiplam was approved by the FDA in August 2020 for use in patients 2 months of age or older in the treatment of spinal muscular atrophy (SMA). Set to be substantially cheaper than other available SMA therapies, risdiplam appears to provide a novel and relatively accessible treatment option for patients with SMA regardless of severity or type.
Risdiplam is a survival of motor neuron 2 (SMN2) splicing modifier.
light yellow powder to yellow powderBasic Info-
Product Name:
Risdiplam
Other Name:7-amino-2,3-dihydro-1H-inden-4-ol;Risdiplam;RO7034067;RG7916;4H-Pyrido[1,2-a]pyrimidin-4-one, 7-(4,7-diazaspiro[2.5]oct-7-yl)-2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-;2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-7-(4,7-diazaspiro[2.5]octan-7-yl)-4H-pyrido[1,2-a]pyrimidin-4-one;Risdiplam (RG-7916, RO-7034067);2H4]-Risdiplam
CAS No.:1825352-65-5
Molecular Formula:C22H23N7O
InChIKeys:ASKZRYGFUPSJPN-UHFFFAOYSA-N
Molecular Weight:401.46
Exact Mass:401.46
EC Number:218-362-5
UNII:76RS4S2ET1
Color/Form:Light yellow to yellow
ATC Code:M09AX10|M - Musculo-skeletal system
Categories:
Characteristics-
Density:
1.50±0.1 g/cm3(Predicted)
PKA:9.41±0.20(Predicted)
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals
-
Location:
Room A, 23rd Floor, No. 609 Yan'an Road, Gongshu District, Hangzhou, Zhejiang
-
Payment Terms:
TT against copy of documents,D/P,L/C
-
Average lead Time:
5 days
-
Total Annual Revenue:
Above $100 million
-
Year of Establishment:
2020
Company Certificates-
ISO
">Company ProfileLEAPChem is a specialized fine chemical supplier for research, development and production.
LEAPChem provides nearly 200,000 rare and innovative chemical products to support the evolving needs of our customers in research & bulk manufacturing activities.
As a highly customer-oriented enterprise, we are committed to providing high-quality customer services and products to our global customers in a cost-effective and efficient manner.
Our client list includes many major pharmaceutical and science companies, universities, research institutions and chemical catalogue companies.
Methodology: Sound & Stable; Active & Innovative.
Attitude: Conscientious; Ingenious.
Goals: Customer's Satisfaction
We regard client's success as our success.
At LEAPChem, we strive to be the preferred supplier for efficiency increasing and cost lowering in your Research & Production.
To achieve this strategic vision, we always push ourselves to exceed our customer's requirement. By focusing on the aim of 'Beyond Your Expectation', we continually expand our product lines, and enhance our systematic management and human resources.
Welcome to contact us and we look forward to becoming your reliable and preferred partner.
-
-
Inquiry History3 Inquiries
Country Product Purchase Quantity Date Posted
India
Risdiplam
1 KG Feb 10, 2026
Sweden
Risdiplam
100 G Jan 29, 2024
Sweden
Risdiplam
1 G Jan 29, 2024 Post an enquiry for this product
More from this Seller
-
-
-
Bromopentafluorobenzene
/ 99.00%
-
-
-
-
Sodium polyacrylate
/ 99.00%
-
-
-
-
6-broMopyrazine-2-carboxylic acid
/ 99.00%
-
-
-
-
2-hydroxy acetaldehyde
/ 99.00%
-
-
-
-
Betamethasone 17-valerate
/ 99.00%
-
-
-
-
Benzene, 1,2-diethynyl- (9CI)
/ 99.00%
-